# Intermittent Dosing Of Selumetinib In Childhood NF1 Associated Tumours

> **NCT03326388** · PHASE1,PHASE2 · COMPLETED · sponsor: **Great Ormond Street Hospital for Children NHS Foundation Trust** · enrollment: 14 (actual)

## Conditions studied

- Neurofibromatosis Type 1
- Plexiform Neurofibroma
- Optic Nerve Glioma

## Interventions

- **DRUG:** Selumetinib

## Key facts

- **NCT ID:** NCT03326388
- **Lead sponsor:** Great Ormond Street Hospital for Children NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-26
- **Primary completion:** 2024-02-14
- **Final completion:** 2024-02-14
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2024-04-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03326388

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03326388, "Intermittent Dosing Of Selumetinib In Childhood NF1 Associated Tumours". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03326388. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*